论文信息 - Results of a phase 2 trial of selinexor, an oral selective inhibitor of nuclear export (SINE) in 114 patients with gynaecological cancers - 字舞流文

Results of a phase 2 trial of selinexor, an oral selective inhibitor of nuclear export (SINE) in 114 patients with gynaecological cancers

P. Neven | I. Vergote | T. Juhler-Nøttrup | M. Mirza | E. Nieuwenhuysen | Y. Landesman | S. Shacham | C. Haslund | M. Mau-Sørensen | M. Crochiere | H. Havsteen | P. Berteloot | B. Lund | M. Kauffman | Z. Ujmajuridze | A. Kranich | George Wright | T. Rashal | J. Meade | J. Saint-Martin